2024
Development of a Shigella conjugate vaccine targeting Shigella flexneri 6 that is immunogenic and provides protection against virulent challenge
Kelly M, Janardhanan J, Wagh C, Verma S, Charles R, Leung D, Kamruzzaman M, Pansuriya R, Chowdhury F, Vann W, Kaminski R, Khan A, Bhuiyan T, Qadri F, Kováč P, Xu P, Ryan E. Development of a Shigella conjugate vaccine targeting Shigella flexneri 6 that is immunogenic and provides protection against virulent challenge. Vaccine 2024, 42: 126263. PMID: 39217775, PMCID: PMC11409015, DOI: 10.1016/j.vaccine.2024.126263.Peer-Reviewed Original ResearchS. flexneri 6O-specific polysaccharideS. flexneri 3aShigella flexneri 2aShigella flexneri 6Component of lipopolysaccharideSerotype-specific monoclonal antibodiesS. sonneiShigella speciesFlexneri 2aShigella infectionShigella vaccineCarrier proteinHeavy chainBactericidal antibody responsesShigellaShigellosisVaccinated miceConjugate vaccineSerum of humansIgG responsesImmune responseLethal challengeAntibody responseIgM response
2002
Pathogenicity Islands of Shigella
Ingersoll M, Groisman EA, Zychlinsky A. Pathogenicity Islands of Shigella. Current Topics In Microbiology And Immunology 2002, 264: 49-65. PMID: 12014181, DOI: 10.1007/978-3-662-09217-0_4.Peer-Reviewed Original ResearchPathogenicity Islands of Shigella
Ingersoll M, Groisman E, Zychlinsky A. Pathogenicity Islands of Shigella. Current Topics In Microbiology And Immunology 2002, 264/2: 49-65. DOI: 10.1007/978-3-642-56031-6_4.Peer-Reviewed Original ResearchIntestinal epithelial barrierResident tissue macrophagesAbdominal crampsLymphoid folliclesMild diarrheaSevere formTissue macrophagesEpithelial barrierEnteric pathogensShigella speciesBacillary dysenteryM cellsDisease rangeCausative agentShigellaeHost cell cytoplasmHuman pathogensShigellaPathogenicity islandDisease symptoms
1994
Acute bacterial diarrhoea in the emergency room: therapeutic implications of stool culture results.
Kaminski N, Bogomolski V, Stalnikowicz R. Acute bacterial diarrhoea in the emergency room: therapeutic implications of stool culture results. Emergency Medicine Journal 1994, 11: 168. PMID: 7804582, PMCID: PMC1342424, DOI: 10.1136/emj.11.3.168.Peer-Reviewed Original ResearchMeSH KeywordsAcute DiseaseAdolescentAdultAgedAged, 80 and overAmpicillinBacterial InfectionsBacteriological TechniquesChildChild, PreschoolCiprofloxacinDiarrheaDrug Resistance, MicrobialDysentery, BacillaryEmergency Service, HospitalEscherichia coli InfectionsFecesHumansInfantMicrobial Sensitivity TestsMiddle AgedSalmonella InfectionsTrimethoprim, Sulfamethoxazole Drug CombinationConceptsTrimethoprim-sulfamethoxazoleEmergency roomStool culture resultsTreatment of choiceAcute diarrhoeal diseaseAcute bacterial diarrheaEmergence of resistanceEmpiric treatmentAcute diarrheaStool culturesShigella isolatesBacterial diarrheaNew quinolonesSick patientsTherapeutic implicationsDiarrhoeal diseaseCulture resultsDrug resistanceShigella speciesPatientsStudy periodShigella sonneiAntimicrobial resistanceAntimicrobial drugsDiarrhea
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply